Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis

Journal of Experimental Medicine

Volumn 189, Issue 12, 1999, Pages 1973-1980

  Behar, Samuel M ^a   Dascher, Chris C ^a   Grusby, Michael J ^a,b   Wang, Chyung Ru ^c   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

CD1; CD8; Infection; Mycobacterium tuberculosis; Transporter associated with antigen processing

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; INFECTION SENSITIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS;

ANIMALS; ANTIGENS, CD1; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; LUNG; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; STEM CELLS; TUBERCULOSIS;

EID: 0033591685     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.12.1973     Document Type: Article

References (45)

1. World Health Organization. 1998. Global Tuberculosis Programme. Tuberculosis Fact Sheet. WHO, Geneva, http:// www.who.int/gtb/publications/factsheet/index.htm
2. Russell, D.G., J. Dant, and S. Sturgill-Koszycki. 1996. Mycobactcrium avium-and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma. J. Immunol. 156:4764-4773.
3. Muller, I., S.P. Cobbold, H. Waldmann, and S.H. Kaufmann. 1987. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect. Immun. 55:2037-2041.
4. Orme, I.M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138:293-298.
5. Orme, I.M., and P.M. Collins. 1983. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J. Exp. Med. 158:74-83.
6. Orme, I.M., and F.M. Collins. 1984. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell. Immunol. 84:113-120.
7. Pedrazzini, T., K. Hug, and J.A. Louis. 1987. Importance of L3T4+ and Lyt-2+ cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guerin in mice. Assessment by elimination of T cell subsets in vivo. J. Immunol. 139:2032-2037.
8. Cox, J.H., B.C. Knight, and J. Ivanyi. 1989. Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice. Infect. Immun. 57:1719-1724.
9. + T cells. J. Exp. Med. 176:581-586.
10. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 95:270-275.
11. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 187:1633-1640.
12. Flynn, J.L., M.M. Goldstein, K.J. Triebold, B. Koller, and B.R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA. 89:12013-12017.
13. Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar, S.T. Furlong, and M.B. Brenner. 1994. Recognition of a lipid antigen by CD 1-restricted alpha beta+ T cells. Nature. 372:691-694.
14. Moody, D.B., B.B. Reinhold, M.R. Guy, E.M. Beckman, D.E. Frederique, S.T. Furlong, S. Ye, V.N. Reinhold, P.A. Siding, R.L. Modlin, et al. 1997. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 278:283-286.
15. Sieling, P.A., D. Chatterjee, S.A. Porcelli, T.I. Prigozy, R.J. Mazzaccaro, T. Soriano, B.R. Bloom, M.B. Brenner, M. Kronenberg, and P.J. Brennan. 1995. CD1-restricted T cell recognition of nucrobial lipoglycan antigens. Science. 269: 227-230.
16. Joyce, S., A.S. Woods, J.W. Yewdell, J.R. Bennink, A.D. De Silva, A. Boesteanu, S.P. Balk, R.J. Cotter, and R.R. Brutkiewicz. 1998. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 279:1541-1544.
17. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
18. Spada, F.M., Y. Koezuka, and S.A. Porcelli. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1529-1534.
19. Behar, S.M., T.A. Podrebarac, C.J. Roy, C.R. Wang, and M.B. Brenner. 1999. Diverse TCRs recognize murine CD1. J. Immunol. 162:161-167.
20. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182:993-1004.
21. Park, S.H., J.H. Roark, and A. Bendelac. 1998. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160: 3128-3134.
22. Plamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16: 323-358.
23. + T cells in Tap-1 mutant mice. Proc. Natl. Acad. Sci. USA. 91:6525-6528.
24. Hanau, D., D. Fricker, T. Bieber, M.E. Esposito-Farese, H. Bausinger, J.P. Cazenave, L. Donato, M.M. Tongio, and H. de la Salle. 1994. CD1 expression is not affected by human peptide transporter deficiency. Hum. Immunol. 41:61-68.
25. + T cells from a patient with rheumatoid arthritis are autoreactive. Arthritis Rheum. 41:498-506.
26. + T cells. Cell. 71:1205-1214.
27. + T cell development and early IL-4 production in CD1-deficient mice. Immunity. 6:459-467.
28. Smiley, ST., M.H. Kaplan, and M.J. Grusby. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting GD1-dependent cells. Science. 275:977-979.
29. Fite, G.L., P.J. Cambre, and M.H. Turner. 1947. Procedure for demonstrating lepra bacilli in paraffin sections. Arch. Pathol. 43:624-625.
30. Ljunggren, H.G., L. Van Kaer, H.L. Ploegh, and S. Tonegawa. 1994. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc. Natl. Acad. Sci. USA. 91:6520-6524.
31. Pamer, E.G., C.R. Wang, L. Flaherty, K.F. Lindahl, and M.J. Bevan. 1992. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell. 70:215-223.
32. Stenger, S., R.J. Mazzaccaro, K. Uyemura, S. Cho, P.F. Barnes, J.P. Rosat, A. Sette, M.B. Brenner, S.A. Porcelli, B.R. Bloom, and R.L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science. 276: 1684-1687.
33. Stenger, S., D.A. Hanson, R. Teitelbaum, P. Dewan, K.R. Niazi, C.J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 282:121-125.
34. Cheroutre, H., H.R. Holcombe, S. Tangri, A.R. Castano, M. Teitell, J.E. Miller, S. Cardell, C. Benoist, D. Mathis, W.D. Huse, et al. 1995. Antigen-presenting function of the TL antigen and mouse CD1 molecules, Immunol. Rev. 147: 31-52.
35. Lindahl, K.F., D.E. Byers, V.M. Dabhi, R. Hovik, E.P. Jones, G.P. Smith, C.R. Wang, H. Xiao, and M. Yoshino. 1997. H2-M3, a full-service class Ib histocompatibility antigen. Annu. Rev. Immunol 15:851-879.
36. Wilson, S.B., S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature. 391:177-181.
37. Tompkins, S.M., J.R. Kraft, C.T. Dao, M.J. Soloski, and P.E. Jensen. 1998. Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to α/β T cells by the class Ib gene product, Qa-1(b). J. Exp. Med. 188:961-971.
38. Rodgers, J.R., V. Mehta, and R.G. Cook. 1995. Surface expression of beta 2-microglobulin-associated thymus-leukemia antigen is independent of TAP2. Eur. J. Immunol. 25: 1001-1007.
39. Lenz, L.L., B. Dere, and M.J. Bevan. 1996. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity. 5:63-72.
40. Bouwer, H.G., M.S. Seaman, J. Forman, and D.J. Hinrichs. 1997. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J. Immunol. 159:2795-2801.
41. Tabaczewski, P., and I. Stroynowski. 1994. Expression of secreted and glycosylphosphatidylinositol-bound Qa-2 molecules is dependent on functional TAP-2 peptide transporter. J. Immunol. 152:5268-5274.
42. +) T cells that express α/β T cell receptors in transporters associated with antigen presentation 1-null and thymus leukemia antigen-positive mice. J. Exp. Med. 184: 1579-1584.
43. Laochumroonvorapong, P., J. Wang, C.C. Liu, W. Ye, A.L. Moreira, K.B. Elkon, V.H. Freedman, and G. Kaplan. 1997. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 65:127-132.
44. Cooper, A.M., C. D'Souza, A.A. Frank, and I.M. Orme. 1997. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perform-or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65: 1317-1320.
45. + T cells requires the production of gamma interferon. Infect. Immun. 66:830-834.